These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 2062419)

  • 1. Epidemiological investigation of the association between infectious mononucleosis and multiple sclerosis.
    Lindberg C; Andersen O; Vahlne A; Dalton M; Runmarker B
    Neuroepidemiology; 1991; 10(2):62-5. PubMed ID: 2062419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Infectious Mononucleosis in Childhood and Adolescence With Risk for a Subsequent Multiple Sclerosis Diagnosis Among Siblings.
    Xu Y; Hiyoshi A; Smith KA; Piehl F; Olsson T; Fall K; Montgomery S
    JAMA Netw Open; 2021 Oct; 4(10):e2124932. PubMed ID: 34633426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis.
    Thacker EL; Mirzaei F; Ascherio A
    Ann Neurol; 2006 Mar; 59(3):499-503. PubMed ID: 16502434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple sclerosis after infectious mononucleosis.
    Nielsen TR; Rostgaard K; Nielsen NM; Koch-Henriksen N; Haahr S; Sørensen PS; Hjalgrim H
    Arch Neurol; 2007 Jan; 64(1):72-5. PubMed ID: 17210811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infectious mononucleosis and multiple sclerosis - Updated review on associated risk.
    Sheik-Ali S
    Mult Scler Relat Disord; 2017 May; 14():56-59. PubMed ID: 28619433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity interacts with infectious mononucleosis in risk of multiple sclerosis.
    Hedström AK; Lima Bomfim I; Hillert J; Olsson T; Alfredsson L
    Eur J Neurol; 2015 Mar; 22(3):578-e38. PubMed ID: 25530445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple sclerosis after infectious mononucleosis: record linkage study.
    Goldacre MJ; Wotton CJ; Seagroatt V; Yeates D
    J Epidemiol Community Health; 2004 Dec; 58(12):1032-5. PubMed ID: 15547068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Season of infectious mononucleosis as a risk factor for multiple sclerosis: A UK primary care case-control study.
    Downham C; Visser E; Vickers M; Counsell C
    Mult Scler Relat Disord; 2017 Oct; 17():103-106. PubMed ID: 29055437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Season of infectious mononucleosis and risk of multiple sclerosis at different latitudes; the EnvIMS Study.
    Lossius A; Riise T; Pugliatti M; Bjørnevik K; Casetta I; Drulovic J; Granieri E; Kampman MT; Landtblom AM; Lauer K; Magalhaes S; Myhr KM; Pekmezovic T; Wesnes K; Wolfson C; Holmøy T
    Mult Scler; 2014 May; 20(6):669-74. PubMed ID: 24072723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis.
    Handel AE; Williamson AJ; Disanto G; Handunnetthi L; Giovannoni G; Ramagopalan SV
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20824132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple sclerosis and infectious childhood diseases.
    Bachmann S; Kesselring J
    Neuroepidemiology; 1998; 17(3):154-60. PubMed ID: 9648121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased risk of multiple sclerosis after late Epstein-Barr virus infection: a historical prospective study.
    Haahr S; Koch-Henriksen N; Møller-Larsen A; Eriksen LS; Andersen HM
    Mult Scler; 1995 Jun; 1(2):73-7. PubMed ID: 9345455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal immunoreactivity in people with or without previous infectious mononucleosis.
    Jons D; Zetterberg H; Malmeström C; Bergström T; Axelsson M; Blennow K; Thulin M; Sundström P; Andersen O
    Acta Neurol Scand; 2020 Aug; 142(2):161-168. PubMed ID: 32415852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis.
    Nielsen TR; Rostgaard K; Askling J; Steffensen R; Oturai A; Jersild C; Koch-Henriksen N; Sørensen PS; Hjalgrim H
    Mult Scler; 2009 Apr; 15(4):431-6. PubMed ID: 19153174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A population-based case-control study on viral infections and vaccinations and subsequent multiple sclerosis risk.
    Ahlgren C; Torén K; Odén A; Andersen O
    Eur J Epidemiol; 2009; 24(9):541-52. PubMed ID: 19633994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus is a necessary causative agent in the pathogenesis of multiple sclerosis: no.
    Salzer J; Myhr KM
    Mult Scler; 2013 Nov; 19(13):1692-3. PubMed ID: 24218487
    [No Abstract]   [Full Text] [Related]  

  • 17. Infectious mononucleosis is associated with an increased incidence of multiple sclerosis: Results from a cohort study of 32,116 outpatients in Germany.
    Loosen SH; Doege C; Meuth SG; Luedde T; Kostev K; Roderburg C
    Front Immunol; 2022; 13():937583. PubMed ID: 35983044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative interaction between smoking and EBV in the risk of multiple sclerosis: The EnvIMS study.
    Bjørnevik K; Riise T; Bostrom I; Casetta I; Cortese M; Granieri E; Holmøy T; Kampman MT; Landtblom AM; Magalhaes S; Pugliatti M; Wolfson C; Myhr KM
    Mult Scler; 2017 Jun; 23(7):1018-1024. PubMed ID: 27663872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of multiple sclerosis in individuals with infectious mononucleosis: a national population-based cohort study using hospital records in England, 2003-2023.
    Goldacre R
    Mult Scler; 2024 Apr; 30(4-5):489-495. PubMed ID: 38511730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary Epstein-Barr virus infection with and without infectious mononucleosis.
    Rostgaard K; Balfour HH; Jarrett R; Erikstrup C; Pedersen O; Ullum H; Nielsen LP; Voldstedlund M; Hjalgrim H
    PLoS One; 2019; 14(12):e0226436. PubMed ID: 31846480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.